Hypertrophy of the Spinalis Cervicis Muscle in Cervical Dystonia

BACKGROUND: Botulinum neurotoxin A (BoNT) is the first line treatment for cervical dystonia (CD) and treatment outcome significantly depends on the correct identification of the muscles involved. PHENOMENOLOGY SHOWN: In a case with insufficient response to BoNT treatment further work up with magneti...

Descripción completa

Detalles Bibliográficos
Autores principales: Loens, Sebastian, Boppel, Tobias, Bäumer, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2023
Materias:
Teaching Neuroimage
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637288/
https://www.ncbi.nlm.nih.gov/pubmed/37954036
http://dx.doi.org/10.5334/tohm.811
Descripción
Sumario:BACKGROUND: Botulinum neurotoxin A (BoNT) is the first line treatment for cervical dystonia (CD) and treatment outcome significantly depends on the correct identification of the muscles involved. PHENOMENOLOGY SHOWN: In a case with insufficient response to BoNT treatment further work up with magnetic resonance imaging (MRI) of the neck revealed a hypertrophic spinalis cervicis muscle, that is not commonly involved in CD. EDUCATIONAL VALUE: This highlights the use of MRI for muscle selection in treatment refractory CD cases.

Ejemplares similares